Page 44 - AN-4-2

Advanced Neurology SARS-CoV-2 mechanisms of neurological impact

doi: 10.3390/biom11101520 Front Immunol. 2023;14:1240089.
198. Catalogna M, Sasson E, Hadanny A, Parag Y, Zilberman- doi: 10.3389/fimmu.2023.1240089
Itskovich S, Efrati S. Effects of hyperbaric oxygen therapy on 209. Pimentel V, Luchsinger VW, Carvalho GL, et al. Guillain-
functional and structural connectivity in post-COVID-19
condition patients: A randomized, sham-controlled trial. barre syndrome associated with COVID-19: A systematic
Neuroimage Clin. 2022;36:103218. review. Brain Behav Immun Health. 2023;28:100578.
doi: 10.1016/j.bbih.2022.100578
doi: 10.1016/j.nicl.2022.103218
210. Zaa CA, Espitia C, Reyes-Barrera KL, An Z, Velasco-
199. Li J, Zheng M, Shimoni O, et al. Development of novel
therapeutics targeting the blood-brain barrier: From barrier Velazquez MA. Neuroprotective agents with therapeutic
to carrier. Adv Sci (Weinh). 2021;8(16):e2101090. potential for COVID-19. Biomolecules. 2023;13(11):1585.
doi: 10.3390/biom13111585
doi: 10.1002/advs.202101090
200. Khaledi M, Sameni F, Yahyazade S, et al. COVID-19 and the 211. Lindan CE, Mankad K, Ram D, et al. Neuroimaging
potential of Janus Family Kinase (JAK) pathway inhibition: manifestations in children with SARS-CoV-2 infection:
A novel treatment strategy. Front Med (Lausanne). A multinational, multicentre collaborative study. Lancet
2022;9:961027. Child Adolesc Health. 2021;5(3):167‑177.
doi: 10.3389/fmed.2022.961027 doi: 10.1016/S2352-4642(20)30362-X
201. Zizzo G, Tamburello A, Castelnovo L, et al. Immunotherapy 212. C-MORE/PHOSP-COVID Collaborative Group. Multiorgan
of COVID-19: Inside and beyond IL-6 signalling. Front MRI findings after hospitalisation with COVID-19 in the
Immunol. 2022;13:795315. UK (C-MORE): A prospective, multicentre, observational
cohort study. Lancet Respir Med. 2023;11(11):1003‑1019.
doi: 10.3389/fimmu.2022.795315
doi: 10.1016/S2213-2600(23)00262-X
202. Akanchise T, Angelova A. Ginkgo biloba and long
COVID: In vivo and in vitro models for the evaluation of 213. Lu Y, Li X, Geng D, et al. Cerebral micro-structural changes
nanotherapeutic efficacy. Pharmaceutics. 2023;15(5):1562. in COVID-19 patients - an MRI-based 3-month follow-up
study. EClinicalMedicine. 2020;25:100484.
doi: 10.3390/pharmaceutics15051562
doi: 10.1016/j.eclinm.2020.100484
203. Leira EC, Russman AN, Biller J, et al. Preserving stroke
care during the COVID-19 pandemic: Potential issues and 214. Castellano A, Anzalone N, Pontesilli S, Fominskiy E,
solutions. Neurology. 2020;95(3):124‑133. Falini A. Pathological brain CT scans in severe COVID-19
ICU patients. Intensive Care Med. 2020;46(11):2102‑2104.
doi: 10.1212/WNL.0000000000009713
doi: 10.1007/s00134-020-06222-z
204. Ferrone SR, Sanmartin MX, Ohara J, et al. Acute
ischemic stroke outcomes in patients with COVID-19: 215. Varadarajan V, Shabani M, Ambale Venkatesh B, Lima JAC.
A systematic review and meta-analysis. J Neurointerv Surg. Role of imaging in diagnosis and management of COVID-
2024;16(4):333‑341. 19: A multiorgan multimodality imaging review. Front Med
(Lausanne). 2021;8:765975.
doi: 10.1136/jnis‑2023‑020489
doi: 10.3389/fmed.2021.765975
205. Siahaan YMT, Puspitasari V, Pangestu A. COVID-19-
associated encephalopathy: Systematic review of case 216. Egbert AR, Cankurtaran S, Karpiak S. Brain abnormalities
reports. J Clin Neurol. 2022;18(2):194‑206. in COVID-19 acute/subacute phase: A rapid systematic
review. Brain Behav Immun. 2020;89:543‑554.
doi: 10.3988/jcn.2022.18.2.194
doi: 10.1016/j.bbi.2020.07.014
206. Muccioli L, Pensato U, Bernabe G, et al. Intravenous
immunoglobulin therapy in COVID-19-related 217. Van Lith TJ, Sluis WM, Wijers NT, et al. Prevalence and
encephalopathy. J Neurol. 2021;268(8):2671‑2675. 3-month follow-up of cerebrovascular MRI markers in
hospitalized COVID-19 patients: The CORONIS study.
doi: 10.1007/s00415-020-10248-0
Neuroradiology. 2024;66(9):1565‑1575.
207. Stoian A, Stoian M, Bajko Z, et al. Autoimmune encephalitis doi: 10.1007/s00234-024-03411-1
in COVID-19 infection: Our experience and systematic
review of the literature. Biomedicines. 2022;10(4):774. 218. Choi Y, Lee MK. Neuroimaging findings of brain MRI and
CT in patients with COVID-19: A systematic review and
doi: 10.3390/biomedicines10040774
meta-analysis. Eur J Radiol. 2020;133:109393.
208. Liu CH, Chiu LC, Lee CC, Chan TM. Case report: High-dose
steroid and IVIG successful treatment in a case of COVID- doi: 10.1016/j.ejrad.2020.109393
19-associated autoimmune encephalitis: A literature review. 219. Qin Y, Wu J, Chen T, et al. Long-term microstructure and

Volume 4 Issue 2 (2025) 38 doi: 10.36922/an.4909